Ambulatory blood pressure monitoring and type 2 diabetes mellitus;Monitorização ambulatorial da pressão arterial e diabete melito tipo 2

Arquivos Brasileiros de Cardiologia

Volumn 89, Issue 5, 2007, Pages 347-353

  Leitão, Cristiane Bauermann ^a   Canani, Luís Henrique ^a   Silveiro, Sandra Pinho ^a   Gross, Jorge Luiz ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Blood pressure monitoring, ambulatory; Diabetes mellitus type 2

Indexed keywords

BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PROGNOSIS; REVIEW; RISK ASSESSMENT; TREATMENT INDICATION; WHITE COAT HYPERTENSION;

EID: 37349110331     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Scheffel RS, Bortolanza D, Weber CS, Costa LA, Canani LH, Santos KG, et al. Prevalence of micro and macroangiopatic chronic complications and their risk factors in the care of out patients with type 2 diabetes mellitus. Rev Assoc Med Bras.2004; 50: 263-7.
2. Bruno RM, Gross JL. Prognostic factors in Brazilian diabetic patients starting dialysis: a 3.6-year follow-up study. J Diabet Complications.2000; 14: 266-71.
3. Gross JL, Stein AC, Beck MO, Fuchs SC, Silveiro SP, Azevedo MJ, et al. Risk factors for development of proteinuria by type II (non-insulin dependent) diabetic patients. Braz J Med Biol Res.1993; 26: 1269-78.
4. Matthews DR, Stratton IM, Aldington SJ, Holman RR, Kohner EM. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Arch Ophthalmol.2004; 122: 1631-40.
5. Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia.2006; 49: 1761-9.
6. Gross JL, Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care.2005; 28: 164-76.
7. Canani LH, Gerchman F, Gross JL. Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. Diabetes.1999; 48: 909-13.
8. Krolewski AS, Poznik GD, Placha G, Canani L, Dunn J, Walker W, et al. A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes. Kidney Int.2006; 69: 129-36.
9. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ.1998; 317: 703-13.
10. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet.1998; 352: 837-53.
11. Remuzzi G, Schieppati A, Ruggenenti P. Clinical practice: nephropathy in patients with type 2 diabetes. N Engl J Med.2002; 346: 1145-51.
12. Pecis M, Azevedo MJ, Gross JL. Glomerular hyperfiltration is associated with blood pressure abnormalities in normotensive normoalbuminuric IDDM patients. Diabetes Care.1997; 20: 1329-33.
13. Leitão CB, Canani LH, Bolson PB, Molon MP, Pinotti AF, Gross JL. Urinary albumin excretion rate is associated with increased ambulatory blood pressure in normoalbuminuric type 2 diabetic patients. Diabetes Care.2005; 28: 1724-9.
14. Hinman AT, Engel BT, Bickford AF. Portable blood pressure recorder. Accuracy and preliminary use in evaluating intradaily variations in pressure. Am Heart J.1962; 63: 663-8.
15. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension.2005; 45: 142-61.
16. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360: 1903-13.
17. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000; 321: 412-9.
18. Cuspidi C, Lonati L, Sampieri L, Michev I, Macca G, Rocanova JI, et al. Prevalence of target organ damage in treated hypertensive patients: different impact of clinic and ambulatory blood pressure control. J Hypertens. 2000; 18: 803-9.
19. Khattar RS, Swales JD, Banfield A, Dore C, Senior R, Lahiri A. Prediction of coronary and cerebrovascular morbidity and mortality by direct continuous ambulatory blood pressure monitoring in essential hypertension. Circulation. 1999; 100: 1071-6.
20. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003; 348: 2407-15.
21. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006; 354: 2368-74.
22. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressioni Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation 2001; 104: 1385-92.
23. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005; 111: 1777-83.
24. White WB. Blood pressure load and target organ effects in patients with essential hypertension. J Hypertens Suppl. 1991; 9: S39-41.
25. Blanco F, Gil P, Arco CD, Saez T, Aguilar R, Lara I, et al. Association of clinic and ambulatory blood pressure with vascular damage in the elderly: the EPICARDIAN study. Blood Press Monit. 2006; 11: 329-35.
26. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 2002; 20: 2183-9.
27. Ingelsson E, Bjorklund-Bodegard K, Lind L, Arnlov J, Sundstrom J. Diurnal blood pressure pattern and risk of congestive heart failure. JAMA. 2006; 295: 2859-66.
28. III Guidelines for the Use of Ambulatory Blood Pressure Monitoring - ambulatory monitoring of blood pressure. Sociedade Brasileira de Hipertensão. Arq Bras Cardiol. 2001; 77: 384-9.
29. Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. Circulation. 1998; 98: 1892-7.
30. Kario K, Shimada K, Schwartz JE, Matsuo T, Hoshide S, Pickering TG. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol. 2001; 38: 238-45.
31. Cavallini MC, Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Is white coat hypertension associated with arterial disease or left ventricular hypertrophy? Hypertension. 1995; 26: 413-9.
32. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006; 47: 846-53.
33. Bjorklund K, Lind L, Zethelius B, Andren B, Lithell H. Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation. 2003; 107: 1297-302.
34. Fogari R, Zoppi A, Malamani GD, Lazzari P, Destro M, Corradi L. Ambulatory blood pressure monitoring in normotensive and hypertensive type 2 diabetes: prevalence of impaired diurnal blood pressure patterns. Am J Hypertens. 1993; 6: 1-7.
35. Nakano S, Uchida K, Kigoshi T, Azukizawa S, Iwasaki R, Kaneko M, et al. Circadian rhythm of blood pressure in normotensive NIDDM subjects: its relationship to microvascular complications. Diabetes Care 1991; 14: 707-11.
36. Holl RW, Pavlovic M, Heinze E, Thon A. Circadian blood pressure during the early course of type 1 diabetes: analysis of 1,011 ambulatory blood pressure recordings in 354 adolescents and young adults. Diabetes Care. 1999; 22: 1151-7.
37. Cohen CN, Filho FM, de Fatima Goncalves M, de Brito Gomes M. Early alterations of blood pressure in normotensive and normoalbuminuric Type 1 diabetic patients. Diabetes Res Clin Pract. 2001; 53: 85-90.
38. Poulsen PL, Ebbehoj E, Hansen KW, Mogensen CE. 24-h blood pressure and autonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients. Diabetologia. 1997; 40: 718-25.
39. Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med. 2002; 347: 797-805.
40. Knudsen ST, Poulsen PL, Hansen KW, Ebbehoj E, Bek T, Mogensen CE. Pulse pressure and diurnal blood pressure variation: association with micro- and macrovascular complications in type 2 diabetes. Am J Hypertens. 2002; 15: 244-50.
41. Leitão CB. Monitorização ambulatorial da pressão arterial, excreção urinária de albumina e alterações estruturais cardíacas em pacientes com diabetes melito tipo 2. [tese]. Porto Alegre: Universidade Federal do Rio Grande do Sul; 2007.
42. Poulsen PL, Bek T, Ebbehoj E, Hansen KW, Mogensen CE. 24-h ambulatory blood pressure and retinopathy in normoalbuminuric IDDM patients. Diabetologia. 1998; 41: 105-10.
43. Rodrigues TC, Pecis M, Azevedo MJ, Esteves JF, Gross JL. Ambulatory blood pressure monitoring and progression of retinopathy in normotensive, normoalbuminuric type 1 diabetic patients: a 6-year follow-up study. Diabetes Res Clin Pract. 2006; 74: 135-40.
44. Cohen CN, Albanesi FM, Goncalves MF, Gomes MB. Ambulatory blood pressure monitoring and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus. Arq Bras Cardiol. 2000; 75: 195-204.
45. Darcan S, Goksen D, Mir S, Serdaroglu E, Buyukinan M, Coker M, et al. Alterations of blood pressure in type 1 diabetic children and adolescents. Pediatr Nephrol. 2006; 21: 672-6.
46. Monteagudo PT, Nobrega JC, Cezarini PR, Ferreira SR, Kohlmann Junior O, Ribeiro AB, et al. Altered blood pressure profile, autonomic neuropathy and nephropathy in insulin-dependent diabetic patients. Eur J Endocrinol. 1996; 135: 683-8.
47. Duvnjak L, Vuckovic S, Car N, Metelko Z. Relationship between autonomic function, 24-h blood pressure, and albuminuria in normotensive, normoalbuminuric patients with Type 1 diabetes. J Diabet Complications. 2001; 15: 314-9.
48. Spallone V, Maiello MR, Cicconetti E, Pannone A, Barini A, Gambardella S, et al. Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetes. J Hum Hypertens. 2001; 15: 239-46.
49. Ferreira SR, Cesarini PR, Vivolo MA, Zanella MT. Abnormal nocturnal blood pressure fall in normotensive adolescents with insulin-dependent diabetes is ameliorated following glycemic improvement. Braz J Med Biol Res. 1998; 31: 523-8.
50. Foss CH, Vestbo E, Froland A, Gjessing HJ, Mogensen CE, Damsgaard EM. Autonomic neuropathy in nondiabetic offspring of type 2 diabetic subjects is associated with urinary albumin excretion rate and 24-h ambulatory blood pressure: the Fredericia Study. Diabetes. 2001; 50: 630-6.
51. Pecis M, Azevedo MJ, Moraes RS, Ferlin EL, Gross JL. Autonomic dysfunction and urinary albumin excretion rate are associated with an abnormal blood pressure pattern in normotensive normoalbuminuric type 1 diabetic patients. Diabetes Care. 2000; 23: 989-93.
52. Equiluz-Bruck S, Schnack C, Kopp HP, Schernthaner G. Nondipping of nocturnal blood pressure is related to urinary albumin excretion rate in patients with type 2 diabetes mellitus. Am J Hypertens. 1996; 9: 1139-43.
53. Rutter MK, McComb JM, Forster J, Brady S, Marshall SM. Increased left ventricular mass index and nocturnal systolic blood pressure in patients with Type 2 diabetes mellitus and microalbuminuria. Diabet Med. 2000; 17: 321-5.
54. Sochett EB, Poon I, Balfe W, Daneman D. Ambulatory blood pressure monitoring in insulin-dependent diabetes mellitus adolescents with and without microalbuminuria. J Diabet Complications. 1998; 12: 18-23.
55. Toth L, Voros P, Lengyel Z, Liptai M, Nemeth C, Kammerer L. Diurnal blood pressure variations in incipient and end stage diabetic renal disease. Diabetes Res Clin Pract. 2000; 49: 1-6.
56. Cohen CN, Albanesi FM, Goncalves MF, Gomes MB. Microalbuminuria, high blood pressure burden, and nondipper phenomenon: an interaction in normotensive type 1 diabetic patients. Diabetes Care. 2001; 24: 790-1.
57. Hansen KW, Mau Pedersen M, Marshall SM, Christiansen JS, Mogensen CE. Circadian variation of blood pressure in patients with diabetic nephropathy. Diabetologia. 1992; 35: 1074-9.
58. Hansen KW, Sorensen K, Christensen PD, Pedersen EB, Christiansen JS, Mogensen CE. Night blood pressure: relation to organ lesions in microalbuminuric type 1 diabetic patients. Diabet Med. 1995; 12: 42-5.
59. Poulsen PL, Hansen KW, Mogensen CE. Ambulatory blood pressure in the transition from normo- to microalbuminuria: a longitudinal study in IDDM patients. Diabetes. 1994; 43: 1248-53.
60. Mogensen CE. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes. J Intern Med. 2003; 254: 45-66.
61. Flores L, Recasens M, Gomis R, Esmatjes E. White coat hypertension in type 1 diabetic patients without nephropathy. Am J Hypertens. 2000; 13: 560-3.
62. Puig JG, Ruilope LM, Ortega R. Antihypertensive treatment efficacy in type II diabetes mellitus. Dissociation between casual and 24-hour ambulatory blood pressure. Spanish Multicenter Study Group. Hypertension. 1995; 26: 1093-9.
63. Nielsen FS, Gaede P, Vedel P, Pedersen O, Parving HH. White coat hypertension in NIDDM patients with and without incipient and overt diabetic nephropathy. Diabetes Care. 1997; 20: 859-63.
64. Leitão CB, Canani LH, Kramer CK, Boza JC, Pinotti AF, Gross JL. Masked hypertension, urinary albumin excretion rate and echocardiographic parameters in putatively normotensive type 2 diabetes mellitus patients. Diabetes Care. 2007; 30:1255-60.
65. Guimaraes JI, Gomes MA, Mion Junior D, Nobre F, Mendonca MA, Cruz LL, et al. Standardization of equipments and techniques for exams of ambulatory blood pressure mapping and home blood pressure monitoring. Arq Bras Cardiol. 2003; 80: 225-33.